These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 30657554)
1. MicroRNA-124 inhibits colorectal cancer cell proliferation and suppresses tumor growth by interacting with PLCB1 and regulating Wnt/β-catenin signaling pathway. Lu ML; Zhang Y; Li J; Fu Y; Li WH; Zhao GF; Li XH; Wei L; Liu GB; Huang H Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):121-136. PubMed ID: 30657554 [TBL] [Abstract][Full Text] [Related]
2. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway. Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162 [TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway. Kong LY; Xue M; Zhang QC; Su CF Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene. Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway. Sun J; Yan P; Chen Y; Chen Y; Yang J; Xu G; Mao H; Qiu Y Diagn Pathol; 2015 Jun; 10():72. PubMed ID: 26088648 [TBL] [Abstract][Full Text] [Related]
6. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells. Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872 [TBL] [Abstract][Full Text] [Related]
7. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop. Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway. Yang S; Li X; Shen W; Hu H; Li C; Han G J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055 [TBL] [Abstract][Full Text] [Related]
9. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation. Liu HR; Zhao J Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):94-107. PubMed ID: 33506897 [TBL] [Abstract][Full Text] [Related]
10. Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway. Mao XW; Xiao JQ; Li ZY; Zheng YC; Zhang N Exp Mol Med; 2018 Jan; 50(1):e429. PubMed ID: 29350680 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1. Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369 [TBL] [Abstract][Full Text] [Related]
12. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway. Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810 [TBL] [Abstract][Full Text] [Related]
13. miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling. Sun N; Zhang L; Zhang C; Yuan Y Cell Mol Biol Lett; 2020; 25():19. PubMed ID: 32206063 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway. Sun WM; Tao W; Li JC; Zhu DM; Miao Y Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196 [TBL] [Abstract][Full Text] [Related]
15. Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/β-catenin pathway. Liu R; Deng P; Zhang Y; Wang Y; Peng C World J Surg Oncol; 2021 Feb; 19(1):51. PubMed ID: 33596920 [TBL] [Abstract][Full Text] [Related]
16. microRNA-374 inhibits proliferation and promotes apoptosis of mouse melanoma cells by inactivating the Wnt signalling pathway through its effect on tyrosinase. Li XJ; Li ZF; Xu YY; Han Z; Liu ZJ J Cell Mol Med; 2019 Aug; 23(8):4991-5005. PubMed ID: 31207106 [TBL] [Abstract][Full Text] [Related]
17. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer. Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-185 is a novel tumor suppressor by negatively modulating the Wnt/β-catenin pathway in human colorectal cancer. Dong-Xu W; Jia L; Su-Juan Z Indian J Cancer; 2015 Dec; 52 Suppl 3():E182-5. PubMed ID: 27453420 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-185 inhibits the growth and proliferation of osteoblasts in fracture healing by targeting PTH gene through down-regulating Wnt/β -catenin axis: In an animal experiment. Yao CJ; Lv Y; Zhang CJ; Jin JX; Xu LH; Jiang J; Geng B; Li H; Xia YY; Wu M Biochem Biophys Res Commun; 2018 Jun; 501(1):55-63. PubMed ID: 29678580 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition. Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]